Global Preterm Labor Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 124 pages | ID: G36E03D1959EN
GlobalInfoResearch

Abstracts

Preterm labor is defined as regular contractions of the uterus resulting in changes in the cervix that start before 37 weeks of pregnancy.

Scope of the Report:

Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market.
The global Preterm Labor Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Preterm Labor Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Preterm Labor Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Preterm Labor Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson and Johnson
• GSK
• AstraZeneca
• Cipla

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Tocolytic Drugs
• Beta – Mimetic
• Calcium Channel Blockers
• NSAIDS
• Corticosteroids
• Magnesium Sulphate
• Antibiotics

Market Segment by Applications, can be divided into

• Hospitals
• Pediatric and Neonatal Clinics
• Nursing Homes
• Pharmacy

Contents

1 PRETERM LABOR TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Preterm Labor Treatment
1.2 Classification of Preterm Labor Treatment by Types
  1.2.1 Global Preterm Labor Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Preterm Labor Treatment Revenue Market Share by Types in 2017
  1.2.3 Tocolytic Drugs
  1.2.4 Beta – Mimetic
  1.2.5 Calcium Channel Blockers
  1.2.6 NSAIDS
  1.2.7 Corticosteroids
  1.2.8 Magnesium Sulphate
  1.2.9 Antibiotics
1.3 Global Preterm Labor Treatment Market by Application
  1.3.1 Global Preterm Labor Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Pediatric and Neonatal Clinics
  1.3.4 Nursing Homes
  1.3.5 Pharmacy
1.4 Global Preterm Labor Treatment Market by Regions
  1.4.1 Global Preterm Labor Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Preterm Labor Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Preterm Labor Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Preterm Labor Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Preterm Labor Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Preterm Labor Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Preterm Labor Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Preterm Labor Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
  2.2.1 Business Overview
  2.2.2 Preterm Labor Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Novartis Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Preterm Labor Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
  2.4.1 Business Overview
  2.4.2 Preterm Labor Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Sanofi Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson and Johnson
  2.5.1 Business Overview
  2.5.2 Preterm Labor Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Johnson and Johnson Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 GSK
  2.6.1 Business Overview
  2.6.2 Preterm Labor Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 GSK Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca
  2.7.1 Business Overview
  2.7.2 Preterm Labor Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 AstraZeneca Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cipla
  2.8.1 Business Overview
  2.8.2 Preterm Labor Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Cipla Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PRETERM LABOR TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Preterm Labor Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Preterm Labor Treatment Players Market Share
  3.2.2 Top 10 Preterm Labor Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL PRETERM LABOR TREATMENT MARKET SIZE BY REGIONS

4.1 Global Preterm Labor Treatment Revenue and Market Share by Regions
4.2 North America Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Preterm Labor Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PRETERM LABOR TREATMENT REVENUE BY COUNTRIES

5.1 North America Preterm Labor Treatment Revenue by Countries (2013-2018)
5.2 USA Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Preterm Labor Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE PRETERM LABOR TREATMENT REVENUE BY COUNTRIES

6.1 Europe Preterm Labor Treatment Revenue by Countries (2013-2018)
6.2 Germany Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
6.4 France Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Preterm Labor Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PRETERM LABOR TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Preterm Labor Treatment Revenue by Countries (2013-2018)
7.2 China Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
7.5 India Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PRETERM LABOR TREATMENT REVENUE BY COUNTRIES

8.1 South America Preterm Labor Treatment Revenue by Countries (2013-2018)
8.2 Brazil Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PRETERM LABOR TREATMENT BY COUNTRIES

9.1 Middle East and Africa Preterm Labor Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Preterm Labor Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL PRETERM LABOR TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Preterm Labor Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Preterm Labor Treatment Market Forecast by Type (2018-2023)
10.3 Tocolytic Drugs Revenue Growth Rate (2013-2023)
10.4 Beta – Mimetic Revenue Growth Rate (2013-2023)
10.5 Calcium Channel Blockers Revenue Growth Rate (2013-2023)
10.6 NSAIDS Revenue Growth Rate (2013-2023)
10.7 Corticosteroids Revenue Growth Rate (2013-2023)
10.8 Magnesium Sulphate Revenue Growth Rate (2013-2023)
10.9 Antibiotics Revenue Growth Rate (2013-2023)

11 GLOBAL PRETERM LABOR TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Preterm Labor Treatment Revenue Market Share by Application (2013-2018)
11.2 Preterm Labor Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Pediatric and Neonatal Clinics Revenue Growth (2013-2018)
11.5 Nursing Homes Revenue Growth (2013-2018)
11.6 Pharmacy Revenue Growth (2013-2018)

12 GLOBAL PRETERM LABOR TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Preterm Labor Treatment Market Size Forecast (2018-2023)
12.2 Global Preterm Labor Treatment Market Forecast by Regions (2018-2023)
12.3 North America Preterm Labor Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Preterm Labor Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Preterm Labor Treatment Revenue Market Forecast (2018-2023)
12.6 South America Preterm Labor Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Preterm Labor Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Preterm Labor Treatment Picture
Table Product Specifications of Preterm Labor Treatment
Table Global Preterm Labor Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Preterm Labor Treatment Revenue Market Share by Types in 2017
Figure Tocolytic Drugs Picture
Figure Beta – Mimetic Picture
Figure Calcium Channel Blockers Picture
Figure NSAIDS Picture
Figure Corticosteroids Picture
Figure Magnesium Sulphate Picture
Figure Antibiotics Picture
Table Global Preterm Labor Treatment Revenue (Million USD) by Application (2013-2023)
Figure Preterm Labor Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Pediatric and Neonatal Clinics Picture
Figure Nursing Homes Picture
Figure Pharmacy Picture
Table Global Market Preterm Labor Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Preterm Labor Treatment Type and Applications
Table Pfizer Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Preterm Labor Treatment Type and Applications
Table Novartis Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Preterm Labor Treatment Type and Applications
Table Merck Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Preterm Labor Treatment Type and Applications
Table Sanofi Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Preterm Labor Treatment Type and Applications
Table Johnson and Johnson Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Preterm Labor Treatment Type and Applications
Table GSK Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Preterm Labor Treatment Type and Applications
Table AstraZeneca Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Preterm Labor Treatment Type and Applications
Table Cipla Preterm Labor Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Preterm Labor Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Preterm Labor Treatment Revenue Share by Players (2013-2018)
Figure Global Preterm Labor Treatment Revenue Share by Players in 2016
Figure Global Preterm Labor Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Preterm Labor Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Preterm Labor Treatment Revenue Market Share in 2017
Figure Global Preterm Labor Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Preterm Labor Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Preterm Labor Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Preterm Labor Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Preterm Labor Treatment Revenue Market Share by Regions in 2017
Figure North America Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure South America Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Table North America Preterm Labor Treatment Revenue by Countries (2013-2018)
Table North America Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Preterm Labor Treatment Revenue Market Share by Countries in 2017
Figure USA Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Table Europe Preterm Labor Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Preterm Labor Treatment Revenue Market Share by Countries in 2017
Figure Germany Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure UK Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure France Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Preterm Labor Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Preterm Labor Treatment Revenue Market Share by Countries in 2017
Figure China Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure India Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Table South America Preterm Labor Treatment Revenue by Countries (2013-2018)
Table South America Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Preterm Labor Treatment Revenue Market Share by Countries in 2017
Figure Brazil Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Preterm Labor Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Preterm Labor Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Preterm Labor Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Preterm Labor Treatment Revenue and Growth Rate (2013-2018)
Table Global Preterm Labor Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Preterm Labor Treatment Revenue Share by Type (2013-2018)
Figure Global Preterm Labor Treatment Revenue Share by Type (2013-2018)
Figure Global Preterm Labor Treatment Revenue Share by Type in 2017
Table Global Preterm Labor Treatment Revenue Forecast by Type (2018-2023)
Figure Global Preterm Labor Treatment Market Share Forecast by Type (2018-2023)
Figure Global Tocolytic Drugs Revenue Growth Rate (2013-2018)
Figure Global Beta – Mimetic Revenue Growth Rate (2013-2018)
Figure Global Calcium Channel Blockers Revenue Growth Rate (2013-2018)
Figure Global NSAIDS Revenue Growth Rate (2013-2018)
Figure Global Corticosteroids Revenue Growth Rate (2013-2018)
Figure Global Magnesium Sulphate Revenue Growth Rate (2013-2018)
Figure Global Antibiotics Revenue Growth Rate (2013-2018)
Table Global Preterm Labor Treatment Revenue by Application (2013-2018)
Table Global Preterm Labor Treatment Revenue Share by Application (2013-2018)
Figure Global Preterm Labor Treatment Revenue Share by Application (2013-2018)
Figure Global Preterm Labor Treatment Revenue Share by Application in 2017
Table Global Preterm Labor Treatment Revenue Forecast by Application (2018-2023)
Figure Global Preterm Labor Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Pediatric and Neonatal Clinics Revenue Growth Rate (2013-2018)
Figure Global Nursing Homes Revenue Growth Rate (2013-2018)
Figure Global Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Preterm Labor Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Preterm Labor Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Preterm Labor Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Preterm Labor Treatment Revenue Market Forecast (2018-2023)
Figure Europe Preterm Labor Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Preterm Labor Treatment Revenue Market Forecast (2018-2023)
Figure South America Preterm Labor Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Preterm Labor Treatment Revenue Market Forecast (2018-2023)